President of Fiocruz, Mario Moreira was elected president of the Pasteur Network last Friday (April 4). He succeeds Amadou Sall, CEO of the Institut Pasteur de Dakar (Senegal). The Foundation has been part of the Pasteur Network since 2009 and became an official member in 2015; since then, it has been forging a path of cooperation in support of science, production, innovation, and the training of new talents for accessible healthcare for all, globally.
Recent years have demonstrated such efforts and Fiocruz's leadership role: in 2024, Moreira was elected as the regional representative of the Network for the Americas—a position with a two-year mandate, and the members are part of the Board of Directors of the Association. Also, last year, Fiocruz co-organized the Pasteur Network Annual Meeting in Rio de Janeiro, the first in the Americas. The Pasteur Network is a scientific community comprising over 30 institutions in 25 countries, aiming to promote global health.
"Taking on the presidency of the Pasteur Network board is an honor and a great responsibility. It is a strategic position to strengthen the Network as a whole, the participation of its members, and Fiocruz's role as a leading institution in the institutional development process of the network. Moreover, it is an opportunity to engage in structural cooperation and prepare together to equitably face health crises that affect and will affect the world," stated Mario Moreira.
Pasteur Network
The Pasteur Network is an alliance of over 30 institutes playing a crucial role in addressing global health challenges through science, innovation, and public health. Its distinctive strength lies in its diversity and broad geographic coverage, spanning 25 countries across five continents, fostering a dynamic community of knowledge and expertise. The Pasteur Network is recognized as a non-state actor by the World Health Organization (WHO), and network members are often integrated into local Ministries of Health. The network maintains a global infrastructure that includes over 50 national and regional reference laboratories, several Biosafety Level 3 Laboratories, and 17 WHO Collaborating Centers.